Innovenn Revenue and Competitors

Founded in 2013, Innovenn, Inc. was created with the vision of leveraging clinical and "omics" data to design and develop novel digital therapeutics that improve patient outcomes. To date, Innovenn has served a broad spectrum of clients worldwide by providing pharmaceutical/drug development consulting, medical device development consulting, human factors testing, cloud-based digital therapy software development and software governance services. Innovenn has unique experience in developing and testing Software as a Medical Device (SaMD); we plan and execute clinical validation and analytical testing to support the development and training of unique clinical decision support models including pattern recognition, neural networks, algorithm, machine learning, artificial intelligence (AI), data mining, problem solving. Innovenn has three unique divisions across its subsidiary and affiliates – each committed to excellence and superior quality and each representing one of our areas of expertise: Innovenn (software development), Innovenn Experts (drug/device development consulting), and Improvita (human factors testing of medical devices, combination drug/device products and AI enhanced medical device software development (SaMD)). Additionally, our team brings over 25 years of experience in these areas of expertise with successes on a world-wide scale including the Americas, Europe, and Asia Pacific regions. Together, our broad expertise across these divisions enables us to help our clients launch novel products/technologies that improve patient outcomes and add value to their product portfolios.